A senior scientist at biotherapeutics company HiFiBio Therapeutics, Shen Bingqing was involved in designing the CelliGo single-cell functional antibody screening platform, which can identify antibodies that are potentially of use in creating new medicines for a range of conditions. She has been a contributor to the creation of four patented single-cell analysis and droplet-based microfluidic applications.